PRESS RELEASE published on 04/25/2023 at 14:42, 2 years 7 months ago Halfords Group PLC: Holding(s) in Company*
PRESS RELEASE published on 04/18/2023 at 08:00, 2 years 7 months ago Halfords Group PLC: Capital Markets Day - Leveraging Our Platform
PRESS RELEASE published on 03/31/2023 at 16:30, 2 years 8 months ago Halfords Group PLC: Total Voting Rights
PRESS RELEASE published on 02/28/2023 at 16:45, 2 years 9 months ago Halfords Group PLC: Total Voting Rights
PRESS RELEASE published on 02/13/2023 at 10:00, 2 years 9 months ago Halfords Group PLC: Total Voting Rights
PRESS RELEASE published on 01/25/2023 at 11:49, 2 years 10 months ago Halfords Group PLC: Director/PDMR Shareholding
PRESS RELEASE published on 01/18/2023 at 16:13, 2 years 10 months ago Halfords Group PLC: Holding(s) in Company
PRESS RELEASE published on 01/12/2023 at 08:00, 2 years 10 months ago Halfords Group PLC: Q3 Trading Update: Financial Year 2023
Published on 12/05/2025 at 02:35, 4 hours 58 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 6 hours 33 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 8 hours 28 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 8 hours 33 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 07:00, 33 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 3 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 7 hours 42 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 11 hours 8 minutes ago Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 11 hours 18 minutes ago Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 18:14, 13 hours 18 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 13 hours 33 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 13 hours 33 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 13 hours 48 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 13 hours 48 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL